Regulators should know their place in pharma manufacturing, expert says

31 August 2018

The submission of a manufacturing expert that forms part of the CPhI Annual Industry Report 2018 says that regulators should stick to the task of assuring quality to allow innovation to bring process improvements.

Girish Malhotra, president at EPCOT International, a company focused on simplifying operations and improving technology in manufacturing, has written that pharma companies are in danger of becoming stuck in a rut, where their approach is only to meet regulations and not to consider the potential of process improvements.

He calls for regulators to enable a manufacturing technology innovation environment by shortening approval time to three months.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK